Executive Director, US Medical Affairs, Oncology Solid Tumor Lead

Jazz Pharmaceuticals•US - Home-Based - PA, PA

1d•$304,000 - $456,000•Remote

About The Position

The Executive Director, US Medical Affairs, Oncology for Solid Tumors will report to the VP, Medical Affairs, Oncology and assume a key role within the US Medical Affairs organization. This role will be responsible for the leadership, management, and development of the functional Medical Affairs team supporting the solid tumor portfolio for Jazz Oncology, with a focus on lung and GI. The Executive Director will be responsible for the development and execution of the Medical Affairs’ strategic planning and life cycle management of marketed and in-development products in the solid tumor therapeutic space. This role will be the strategic partner for the Oncology Solid Tumor Commercial Lead and collaborate extensively on the design and execution of deployment of field colleagues in support of the therapeutic space, including the design and execution of account-level cross-functional collaboration, quality engagement, field and payer value, evidence strategy and execution, and serve as an SME in compliant medical design. The Executive Director will lead a team of direct reports with responsibility to design and execute the strategic medical plans in support of product launches, existing indications and lifecycle opportunities, including evidence generation for all US stakeholders. This role will be responsible for the vision of the therapeutic area’(s) treatment landscape to inform the development program and commercial opportunity assessment. The Executive Director will provide direction and support to internal colleagues (development, sales, marketing, regulatory, and clinical) and proactively anticipate risks and opportunities to ensure high performance and best practice execution across all aspects of medical affairs. The Executive Director will determine the medical strategy for professional societies and advocacy across all disease areas for inline and planned solid tumor indications and lead strategic partnerships with key opinion leaders in Oncology. This role will lead all above-brand quality initiatives to advance the standard of care in Oncology and Jazz Pharmaceuticals’ reputation. The Executive Director will be the primary point of contact for corporate communications, public policy and IR for the solid tumor portfolio.

Requirements

12 + years of medical affairs or equivalent experience
Experience in the US market supporting oncology product launches and lifecycle management
Outstanding verbal and written communication skills
Demonstrated ability to influence without authority
Demonstrated success leading medical organizations to deliver best practice support for launch and in line products in oncology
Self-awareness and emotional intelligence as demonstrated by prior experience navigating complex matrix environments successfully

Nice To Haves

PhD, PharmD, MD, DO, Doctor of Nursing, PA
Experience in the delivery of oncology care preferred

Responsibilities

Development, execution, and management of the medical strategy for all in-line indications in the solid tumor portfolio, with a focus on lung and GI
Responsible for US regional input and influence to inform the development strategies for additional lifecycle opportunities in lung and gastrointestinal disease areas
Management of the team of medical affairs colleagues supporting those indications, including budget and personnel
Cross functional alignment and partnership with commercial counterparts to deliver on brand strategies
Partnership with (Global Medical and Scientific Affairs) GMSA organization to align on evidence generation needs and support execution of studies in partnership with HEOR, GV, RWE
Deriving and executing the publication plan in partnership with GMSA
Identifying new opportunities to fully enable the oncology care community to deliver the best care with Jazz assets